A judge on Friday will hear arguments in a bid by BHP Billiton to halt a class action over the mining giant’s Brazilian mine disaster, a sweeping case filed on behalf of investors who held the company’s shares in Australia, the UK or South Africa.
The litigation funder underwriting a class action against Myer will have to fork over another $950,000 in security ahead of what will be a rare shareholder trial starting next Wednesday, a court has ruled.
The first day of a liability hearing in a consumer case over GlaxoSmithKline’s marketing for its popular Voltaren products has seen an ACCC witness deflect accusations the regulator was vague about its misleading packaging concerns, placing the blame squarely on the pharmaceutical giant.
Globe International denies that it violated the law when it sent multiple letters to Kmart allegedly threatening legal action for infringing its copyright for cargo pants and shorts.
One of Australia’s largest debt collectors, ACM Group, harassed and coerced vulnerable customers — including a stroke victim — by bombarding them with phone calls and making empty threats of litigation, the Federal Court found Monday.
A settlement has been reached in two class actions brought on behalf of holders of debentures who allege they suffered losses due to Australian Executor Trustees’ mismanagement of debenture issuer Provident Capital.
The naming of Squire Patton Boggs as a concurrent wrongdoer in GetSwift’s defence puts the law firm in an “impossible position of conflict of interest” if it wins a challenge to an order staying its class action against the company, the Full Federal Court has been told ahead of a highly anticipated appeal hearing that promises to pull no punches.
A judge has denied ASIC’s bid to appoint an interim receiver to preserve the assets of three financial services companies that advised clients to invest in complex derivatives, which ASIC is seeking to have wound up for alleged violations of the Corporations Act.
Two generic drug makers have lost their bid for confidential documents related to Neurim Pharmaceuticals’ patents covering sleep drug Circadin, with a court ruling legal professional privilege was waived in a phone conversation between a DLA Piper lawyer and the company’s founder.
Two rival poppy processors are facing off in another courtroom battle over patents for high codeine-yielding poppy plants.
For information on rights and reprints, contact subscriptions@lawyerly.com.au
